Wugen
Laura Simpson PhD has worked in the regulatory affairs field for over 15 years. Laura began their career in 2005 as an Associate Director at Regeneron Pharmaceuticals. In 2018, they moved to Regeneron Pharmaceuticals, Inc. as a Senior Director of Regulatory Affairs. In 2022, they will become the VP, Head of Regulatory Affairs at Wugen.
Laura Simpson PhD obtained a Doctor of Philosophy - PhD in Cell/Cellular and Molecular Biology from Tulane University between 1992 and 1997. Prior to that, they obtained a Bachelor's degree and a Bachelor of Science - BS in Microbiology, General from Texas A&M University.
This person is not in any offices
Wugen
Wugen is a clinical stage immuno-oncology cell therapy company, developing off-the-shelf NK and CAR-T cell therapies for the treatment of both solid tumor and heme malignancies.